Photo from Eleonora Nicolò/LinkedIn
Jun 30, 2024, 10:58
Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age
Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X:
“Just out in EJC (European Journal of Cancer) our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age.
Age, per se, should not represent a barrier when considering early-phase clinical trials as a treatment option.”
Visit the article website.
Source: Eleonora Nicolò/X
Ambra Carnevale Schianca
Angela Esposito
Antonio Marra
cancer
Carmen Belli
carmen criscitiello
clinical trials
Dario Trapani
efficacy of new drugs
EJC
Eleonora Nicolò
Emanuela Ferraro
European Journal of Cancer
Federica Giugliano
Giuseppe Curigliano
Ida Minchella
Irene Caramella
Jacopo Uliano
Laura Boldrini
Marzia Adelia Locatelli
Massimo Cristofanilli
OncoDaily
Oncology
Oriana D’Ecclesiis
Paola Zagami
Paolo Tarantino
safety of new drugs
Sara Gandini
Stefania Morganti
Weill Cornell Medicine